These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 785682)

  • 1. [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].
    Rouffy J
    Therapie; 1975; 30(6):815-23. PubMed ID: 785682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
    Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
    G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G; Cazzani E; Romanò M; Muzio L
    Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
    Colombo L; Monarca A; Goldberg D; Zanetta R
    Clin Ter; 1979 Oct; 91(2):155-71. PubMed ID: 540479
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
    Di Stefano F; Patane S; Gatto A
    Minerva Med; 1980 Mar; 71(8):567-74. PubMed ID: 7360386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
    Cucinotta D; Palummeri E; Ceccato S; Passeri M
    G Ital Cardiol; 1977; 7(3):248-64. PubMed ID: 858465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].
    Nicrosini F; Pasotti C
    Clin Ter; 1979 Aug; 90(3):241-50. PubMed ID: 553752
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
    Vailati G; Montini M; Simonutti M; Nosari I; Pagani G
    Clin Ter; 1978 May; 85(4):361-73. PubMed ID: 668273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experimentation with a new drug lowering blood lipids (Tiadenol)].
    Potì R; Quintavalla R; Manotti C
    G Clin Med; 1977; 58(7-8):293-300. PubMed ID: 336442
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study on the antilipemic effect of tiadenol (Eulip)].
    Peduzzi L; Cozzi E
    Minerva Med; 1983 Feb; 74(6):249-54. PubMed ID: 6338419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of tiadenol on type IIA hyperlipidemias].
    de Gennes JL; Truffert J; Le Quere JM
    Therapie; 1976; 31(4):455-63. PubMed ID: 188209
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tiadenol in the treatment of primary hyperlipidemias].
    Liguori A; Sibilio G; Mastursi M; Tarzia R; Casale A; Pellegrino G; Varriale A
    G Clin Med; 1981 Jan; 62(1):51-64. PubMed ID: 7227710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tiadenol treatment of hyperlipoproteinemia in maturity onset diabetes].
    Vannini P; Ciavarella A; Motta R; Fiocchi M
    G Clin Med; 1980 Sep; 61(9):687-701. PubMed ID: 7009295
    [No Abstract]   [Full Text] [Related]  

  • 15. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
    [No Abstract]   [Full Text] [Related]  

  • 16. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of the lipid-lowering effect of simvastatin and tiadenol].
    Serra T; Gavelli MS; Vitaliano E; Santini G; Catalano A; Rossi FG; Tozzi J; Caridis R; Guarini G
    Clin Ter; 1990 Mar; 132(5):307-13. PubMed ID: 2139833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CI-719 in hyperlipoproteinaemia: interim data.
    Bremner WF; Third JL; Clark B; Corstorphine C; Lawrie TD
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):83-7. PubMed ID: 798201
    [No Abstract]   [Full Text] [Related]  

  • 19. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
    Warembourg H; Ketelers JY; Ginestet A
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.